- Drug Manufacturers - General
- Healthcare
Bristol-Myers Squibb Company
BMY · US ·
NYSE
42.67
USD
+0.03
(0.07%)
-
-3.04
EPS
-
-14.04
P/E
-
86.5B
MARKET CAP
-
5.55%
DIV YIELD
Executives
Name | Title | Pay |
---|---|---|
Ms. Kimberly M. Jablonski | Chief Compliance & Ethics Officer | -- |
Ms. Ahn Amanda Poole | Executive Vice President & Chief Human Resources Officer | -- |
Ms. Sandra Leung Esq. | Executive Vice President & General Counsel | 2.58M |
Mr. David V. Elkins | Executive Vice President & Chief Financial Officer | 2.28M |
Dr. Joseph J. Eiden Jr. | Head of Medical Affairs | -- |
Mr. Adam Lenkowsky | Executive Vice President, Chief Commercialization Officer & Head of U.S. Oncology | -- |
Dr. Christopher S. Boerner Ph.D. | Chief Executive Officer & Chairman | 3.14M |
Mr. Samit Hirawat M.D. | Executive Vice President, Chief Medical Officer & Head of Development | 2.62M |
Mr. Greg Meyers | Executive Vice President and Chief Digital & Technology Officer | -- |
Mr. Timothy Power | Vice President & Head of Investor Relations | -- |
Insider Transactions
Date | Name | Title | Acquisition Or Disposition | Stock / Options | # of Shares | Price |
---|---|---|---|---|---|---|
2024-07-01 | McMullen Michael R. | director | A - A-Award | Deferred Share Units | 2986.941 | 0 |
2024-07-01 | McMullen Michael R. | - | 0 | 0 | ||
2024-06-30 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 842.764 | 0 |
2024-06-30 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 1203.949 | 0 |
2024-06-30 | Rice Derica W | director | A - A-Award | Deferred Share Units | 902.962 | 0 |
2024-06-30 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 210.691 | 0 |
2024-06-30 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 825.659 | 0 |
2024-05-01 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - J-Other | Market Share Units | 1373 | 0 |
2024-04-01 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | D - M-Exempt | Restricted Stock Units | 3306 | 0 |
2024-04-01 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - M-Exempt | Common Stock, $0.10 par value | 3306 | 0 |
2024-04-01 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | D - F-InKind | Common Stock, $0.10 par value | 1196 | 52.99 |
2024-03-31 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 645.399 | 0 |
2024-03-31 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 691.499 | 0 |
2024-03-31 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 921.999 | 0 |
2024-03-31 | Rice Derica W | director | A - A-Award | Deferred Share Units | 691.499 | 0 |
2024-03-31 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 161.35 | 0 |
2024-03-31 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 645.399 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | A - A-Award | Performance Shares | 31347 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | A - A-Award | Market Share Units | 20898 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 11416 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - J-Other | Common Stock, $0.10 par value | 3974 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 3235 | 53.79 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - J-Other | Market Share Units | 2000 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - J-Other | Market Share Units | 1825 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 1902 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - J-Other | Common Stock, $0.10 par value | 328 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 570 | 53.79 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 1698 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - J-Other | Common Stock, $0.10 par value | 267 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - M-Exempt | Market Share Units | 1902 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 518 | 53.79 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - M-Exempt | Performance Shares | 11416 | 0 |
2024-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - M-Exempt | Market Share Units | 1698 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | A - M-Exempt | Common Stock, $0.10 par value | 35139 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - J-Other | Common Stock, $0.10 par value | 12232 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - F-InKind | Common Stock, $0.10 par value | 11695 | 53.79 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | A - M-Exempt | Common Stock, $0.10 par value | 5856 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - J-Other | Common Stock, $0.10 par value | 1009 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | A - M-Exempt | Common Stock, $0.10 par value | 5789 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - J-Other | Common Stock, $0.10 par value | 912 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - F-InKind | Common Stock, $0.10 par value | 2475 | 53.79 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - F-InKind | Common Stock, $0.10 par value | 2490 | 53.79 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | A - A-Award | Performance Shares | 42957 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | A - A-Award | Market Share Units | 28638 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - J-Other | Market Share Units | 5415 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - J-Other | Market Share Units | 5349 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - M-Exempt | Market Share Units | 5856 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - M-Exempt | Performance Shares | 35139 | 0 |
2024-03-10 | LEUNG SANDRA | EVP, General Counsel | D - M-Exempt | Market Share Units | 5789 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | A - A-Award | Performance Shares | 23220 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | A - A-Award | Market Share Units | 15480 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | A - M-Exempt | Common Stock, $0.10 par value | 6985 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - J-Other | Common Stock, $0.10 par value | 2431 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - F-InKind | Common Stock, $0.10 par value | 1436 | 53.79 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | A - M-Exempt | Common Stock, $0.10 par value | 1164 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - J-Other | Common Stock, $0.10 par value | 201 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - F-InKind | Common Stock, $0.10 par value | 283 | 53.79 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | A - M-Exempt | Common Stock, $0.10 par value | 994 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - J-Other | Common Stock, $0.10 par value | 157 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - F-InKind | Common Stock, $0.10 par value | 246 | 53.79 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - J-Other | Market Share Units | 2342 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - J-Other | Market Share Units | 1107 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - M-Exempt | Market Share Units | 1164 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - M-Exempt | Market Share Units | 994 | 0 |
2024-03-10 | Plenge Robert M | EVP, Chief Research Officer | D - M-Exempt | Performance Shares | 6985 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | A - A-Award | Performance Shares | 17096 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | A - A-Award | Market Share Units | 11397 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | A - M-Exempt | Common Stock, $0.10 par value | 4140 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - J-Other | Common Stock, $0.10 par value | 1441 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - F-InKind | Common Stock, $0.10 par value | 976 | 53.79 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - J-Other | Market Share Units | 803 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - J-Other | Market Share Units | 810 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | A - M-Exempt | Common Stock, $0.10 par value | 690 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - J-Other | Common Stock, $0.10 par value | 119 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - F-InKind | Common Stock, $0.10 par value | 207 | 53.79 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - M-Exempt | Market Share Units | 690 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | A - M-Exempt | Common Stock, $0.10 par value | 628 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - J-Other | Common Stock, $0.10 par value | 99 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - F-InKind | Common Stock, $0.10 par value | 192 | 53.79 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - M-Exempt | Market Share Units | 628 | 0 |
2024-03-10 | Poole Ahn Amanda | EVP, Chief Human Resources | D - M-Exempt | Performance Shares | 4140 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 29311 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - J-Other | Common Stock, $0.10 par value | 10203 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - A-Award | Performance Shares | 60952 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 9774 | 53.79 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 4885 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - J-Other | Common Stock, $0.10 par value | 842 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 4192 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 2068 | 53.79 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - J-Other | Common Stock, $0.10 par value | 660 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 1807 | 53.79 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - A-Award | Market Share Units | 40635 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - J-Other | Market Share Units | 5854 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - J-Other | Market Share Units | 4765 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Market Share Units | 4885 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Market Share Units | 4192 | 0 |
2024-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Performance Shares | 29311 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | A - M-Exempt | Common Stock, $0.10 par value | 4206 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - J-Other | Common Stock, $0.10 par value | 1464 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - F-InKind | Common Stock, $0.10 par value | 992 | 53.79 |
2024-03-10 | Holzer Phil M | SVP and Controller | A - M-Exempt | Common Stock, $0.10 par value | 701 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - J-Other | Common Stock, $0.10 par value | 121 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - F-InKind | Common Stock, $0.10 par value | 210 | 53.79 |
2024-03-10 | Holzer Phil M | SVP and Controller | A - M-Exempt | Common Stock, $0.10 par value | 613 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - J-Other | Common Stock, $0.10 par value | 97 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - F-InKind | Common Stock, $0.10 par value | 187 | 53.79 |
2024-03-10 | Holzer Phil M | SVP and Controller | A - A-Award | Performance Shares | 7407 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | A - A-Award | Market Share Units | 4938 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - J-Other | Market Share Units | 768 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - J-Other | Market Share Units | 810 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - M-Exempt | Market Share Units | 701 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - M-Exempt | Performance Shares | 4206 | 0 |
2024-03-10 | Holzer Phil M | SVP and Controller | D - M-Exempt | Market Share Units | 613 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | A - A-Award | Performance Shares | 7546 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | A - A-Award | Market Share Units | 5031 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | A - M-Exempt | Common Stock, $0.10 par value | 3268 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - J-Other | Market Share Units | 1050 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - J-Other | Common Stock, $0.10 par value | 1138 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - F-InKind | Common Stock, $0.10 par value | 917 | 53.79 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - J-Other | Market Share Units | 835 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | A - M-Exempt | Common Stock, $0.10 par value | 544 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - J-Other | Common Stock, $0.10 par value | 94 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - M-Exempt | Market Share Units | 544 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | A - M-Exempt | Common Stock, $0.10 par value | 539 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - F-InKind | Common Stock, $0.10 par value | 194 | 53.79 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - J-Other | Common Stock, $0.10 par value | 85 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - F-InKind | Common Stock, $0.10 par value | 197 | 53.79 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - M-Exempt | Market Share Units | 539 | 0 |
2024-03-10 | Hoch Lynelle | President, Cell Therapy Org. | D - M-Exempt | Performance Shares | 3268 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | A - A-Award | Performance Shares | 11029 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | A - A-Award | Market Share Units | 7353 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | A - M-Exempt | Common Stock, $0.10 par value | 2094 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - J-Other | Market Share Units | 867 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - J-Other | Common Stock, $0.10 par value | 729 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - J-Other | Market Share Units | 910 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - F-InKind | Common Stock, $0.10 par value | 494 | 53.79 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | A - M-Exempt | Common Stock, $0.10 par value | 349 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - J-Other | Common Stock, $0.10 par value | 60 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - F-InKind | Common Stock, $0.10 par value | 105 | 53.79 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | A - M-Exempt | Common Stock, $0.10 par value | 318 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - J-Other | Common Stock, $0.10 par value | 50 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - F-InKind | Common Stock, $0.10 par value | 97 | 53.79 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - M-Exempt | Market Share Units | 349 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - M-Exempt | Market Share Units | 318 | 0 |
2024-03-10 | Gallman Cari | EVP, Corporate Affairs | D - M-Exempt | Performance Shares | 2094 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - A-Award | Performance Shares | 148026 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - M-Exempt | Common Stock, $0.10 par value | 41910 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - J-Other | Common Stock, $0.10 par value | 14589 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - F-InKind | Common Stock, $0.10 par value | 13975 | 53.79 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - A-Award | Market Share Units | 98684 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - M-Exempt | Common Stock, $0.10 par value | 6985 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - J-Other | Common Stock, $0.10 par value | 1204 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - M-Exempt | Common Stock, $0.10 par value | 5743 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - F-InKind | Common Stock, $0.10 par value | 2957 | 53.79 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - J-Other | Common Stock, $0.10 par value | 905 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - F-InKind | Common Stock, $0.10 par value | 2475 | 53.79 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - J-Other | Market Share Units | 6733 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - J-Other | Market Share Units | 6616 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - M-Exempt | Market Share Units | 6985 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - M-Exempt | Performance Shares | 41910 | 0 |
2024-03-10 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - M-Exempt | Market Share Units | 5743 | 0 |
2024-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - A-Award | Performance Shares | 34830 | 0 |
2024-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - A-Award | Market Share Units | 23220 | 0 |
2024-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | D - J-Other | Market Share Units | 3293 | 0 |
2024-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | D - J-Other | Market Share Units | 2447 | 0 |
2024-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | A - A-Award | Performance Shares | 29025 | 0 |
2024-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | A - A-Award | Market Share Units | 19350 | 0 |
2024-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | D - J-Other | Market Share Units | 3293 | 0 |
2024-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | D - J-Other | Market Share Units | 2836 | 0 |
2024-03-10 | Hickey Benjamin | President, RayzeBio Org. | A - A-Award | Performance Shares | 5805 | 0 |
2024-03-10 | Hickey Benjamin | President, RayzeBio Org. | A - A-Award | Market Share Units | 3870 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 48257 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - J-Other | Common Stock, $0.10 par value | 16798 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 13345 | 53.79 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 8042 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - J-Other | Common Stock, $0.10 par value | 1386 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 2824 | 53.79 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 8027 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - J-Other | Common Stock, $0.10 par value | 1264 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 2353 | 53.79 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | A - A-Award | Performance Shares | 62693 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | A - A-Award | Market Share Units | 41796 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - J-Other | Market Share Units | 7904 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - J-Other | Market Share Units | 7652 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Market Share Units | 8042 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Performance Shares | 48257 | 0 |
2024-03-10 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Market Share Units | 8027 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | A - M-Exempt | Common Stock, $0.10 par value | 142904 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - J-Other | Common Stock, $0.10 par value | 49745 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - F-InKind | Common Stock, $0.10 par value | 47651 | 53.79 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | A - M-Exempt | Common Stock, $0.10 par value | 23817 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - J-Other | Common Stock, $0.10 par value | 4104 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | A - M-Exempt | Common Stock, $0.10 par value | 23409 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - J-Other | Common Stock, $0.10 par value | 3687 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - F-InKind | Common Stock, $0.10 par value | 10084 | 53.79 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - F-InKind | Common Stock, $0.10 par value | 10088 | 53.79 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - J-Other | Market Share Units | 23419 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - J-Other | Market Share Units | 22214 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - M-Exempt | Market Share Units | 23817 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - M-Exempt | Market Share Units | 23409 | 0 |
2024-03-10 | Caforio Giovanni | Executive Chair of the Board | D - M-Exempt | Performance Shares | 142904 | 0 |
2024-03-01 | Hickey Benjamin | President, RayzeBio Org. | A - A-Award | Restricted Stock Units | 9858 | 0 |
2024-02-26 | Hickey Benjamin | President, RayzeBio Org. | D - | Common Stock, $0.10 par value | 0 | 0 |
2024-02-26 | Hickey Benjamin | President, RayzeBio Org. | I - | Common Stock, $0.10 par value | 0 | 0 |
2024-02-26 | Hickey Benjamin | President, RayzeBio Org. | D - | Restricted Stock Units | 30236 | 0 |
2024-02-15 | Holzer Phil M | SVP and Controller | D - | Common Stock, $0.10 par value | 0 | 0 |
2024-02-15 | Holzer Phil M | SVP and Controller | D - | Market Share Units | 3075 | 0 |
2024-02-15 | Holzer Phil M | SVP and Controller | D - | Performance Shares | 4612 | 0 |
2024-02-01 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Vousden Karen H | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Rice Derica W | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Price Paula A | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Hidalgo Medina Manuel | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Haller Julia A | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 4314.773 | 0 |
2024-02-01 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | A - M-Exempt | Common Stock, $0.10 par value | 2543 | 0 |
2024-02-01 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | D - F-InKind | Common Stock, $0.10 par value | 754 | 48.67 |
2024-02-01 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | D - M-Exempt | Restricted Stock Units | 2543 | 0 |
2024-01-01 | Poole Ahn Amanda | EVP, Chief Human Resources | I - | Common Stock, $0.10 par value | 0 | 0 |
2024-01-01 | Poole Ahn Amanda | EVP, Chief Human Resources | D - | Market Share Units | 3214 | 0 |
2024-01-01 | Poole Ahn Amanda | EVP, Chief Human Resources | D - | Performance Shares | 4822 | 0 |
2023-12-31 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 657.767 | 0 |
2023-12-31 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 706.49 | 0 |
2023-12-31 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 950.107 | 0 |
2023-12-31 | Rice Derica W | director | A - A-Award | Deferred Share Units | 706.49 | 0 |
2023-12-31 | Hidalgo Medina Manuel | director | A - A-Award | Deferred Share Units | 164.442 | 0 |
2023-12-31 | Haller Julia A | director | A - A-Award | Deferred Share Units | 706.49 | 0 |
2023-12-31 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 164.442 | 0 |
2023-12-31 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 657.767 | 0 |
2023-12-15 | Hoch Lynelle | President, Cell Therapy Org. | D - | Market Share Units | 4202 | 0 |
2023-12-15 | Hoch Lynelle | President, Cell Therapy Org. | D - | Performance Shares | 6304 | 0 |
2023-12-05 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - P-Purchase | Common Stock, $0.10 par value | 2000 | 49.78 |
2023-12-02 | Plenge Robert M | EVP, Chief Research Officer | A - M-Exempt | Common Stock, $0.10 par value | 616 | 0 |
2023-12-02 | Plenge Robert M | EVP, Chief Research Officer | D - F-InKind | Common Stock, $0.10 par value | 274 | 50.1 |
2023-12-02 | Plenge Robert M | EVP, Chief Research Officer | D - M-Exempt | Restricted Stock Units | 616 | 0 |
2023-12-02 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 8792 | 0 |
2023-12-02 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 3730 | 50.1 |
2023-12-02 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Restricted Stock Units | 8792 | 0 |
2023-12-02 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - M-Exempt | Common Stock, $0.10 par value | 2638 | 0 |
2023-12-02 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - F-InKind | Common Stock, $0.10 par value | 1350 | 50.1 |
2023-12-02 | BOERNER CHRISTOPHER S. | Chief Executive Officer | D - M-Exempt | Restricted Stock Units | 2638 | 0 |
2023-11-28 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - P-Purchase | Common Stock, $0.10 par value | 3071 | 48.86 |
2023-11-21 | LEUNG SANDRA | EVP, General Counsel | D - J-Other | Common Stock, $0.10 par value | 9830 | 48.745 |
2023-11-21 | LEUNG SANDRA | EVP, General Counsel | A - J-Other | Common Stock, $0.10 par value | 9830 | 48.745 |
2023-11-20 | Samuels Theodore R. II | director | A - P-Purchase | Common Stock, $0.10 par value | 8500 | 49.81 |
2023-11-01 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - A-Award | Performance Shares | 17788 | 0 |
2023-11-01 | BOERNER CHRISTOPHER S. | Chief Executive Officer | A - A-Award | Market Share Units | 11858 | 0 |
2023-10-10 | Caforio Giovanni | Board Chair and CEO | D - G-Gift | Common Stock, $0.10 par value | 440 | 0 |
2023-10-02 | Gallman Cari | EVP, Corporate Affairs | A - A-Award | Restricted Stock Units | 13675 | 0 |
2023-10-02 | Gallman Cari | EVP, Corporate Affairs | D - | Common Stock, $0.10 par value | 0 | 0 |
2023-10-02 | Gallman Cari | EVP, Corporate Affairs | D - | Restricted Stock Units | 3183 | 0 |
2023-10-02 | Gallman Cari | EVP, Corporate Affairs | D - | Market Share Units | 3468 | 0 |
2023-10-02 | Gallman Cari | EVP, Corporate Affairs | D - | Performance Shares | 5201 | 0 |
2023-09-30 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 581.496 | 0 |
2023-09-30 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 624.569 | 0 |
2023-09-30 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 839.938 | 0 |
2023-09-30 | Rice Derica W | director | A - A-Award | Deferred Share Units | 624.569 | 0 |
2023-09-30 | Haller Julia A | director | A - A-Award | Deferred Share Units | 624.569 | 0 |
2023-09-30 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 145.374 | 0 |
2023-09-30 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 581.496 | 0 |
2023-08-24 | Powell Ann | EVP, Chief Human Resources | D - S-Sale | Common Stock, $0.10 par value | 17986 | 61.25 |
2023-08-03 | Plenge Robert M | EVP, Chief Research Officer | D - S-Sale | Common Stock, $0.10 par value | 732 | 61.14 |
2023-07-03 | Plenge Robert M | EVP, Chief Research Officer | D - | Common Stock, $0.10 par value | 0 | 0 |
2023-07-03 | Plenge Robert M | EVP, Chief Research Officer | I - | Common Stock, $0.10 par value | 0 | 0 |
2023-07-03 | Plenge Robert M | EVP, Chief Research Officer | D - | Option (right to buy) | 16375 | 62.26 |
2023-07-03 | Plenge Robert M | EVP, Chief Research Officer | D - | Restricted Stock Units | 616 | 0 |
2023-07-03 | Plenge Robert M | EVP, Chief Research Officer | D - | Market Share Units | 9368 | 0 |
2023-07-03 | Plenge Robert M | EVP, Chief Research Officer | D - | Performance Shares | 14052 | 0 |
2023-06-30 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 527.756 | 0 |
2023-06-30 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 566.849 | 0 |
2023-06-30 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 762.314 | 0 |
2023-06-30 | Rice Derica W | director | A - A-Award | Deferred Share Units | 566.849 | 0 |
2023-06-30 | Haller Julia A | director | A - A-Award | Deferred Share Units | 553.943 | 0 |
2023-06-30 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 126.919 | 0 |
2023-06-30 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 527.756 | 0 |
2023-07-01 | Weese Michelle | EVP, Corporate Affairs | A - M-Exempt | Common Stock, $0.10 par value | 1885 | 0 |
2023-07-01 | Weese Michelle | EVP, Corporate Affairs | D - M-Exempt | Restricted Stock Units | 1885 | 0 |
2023-07-01 | Weese Michelle | EVP, Corporate Affairs | D - F-InKind | Common Stock, $0.10 par value | 682 | 63.95 |
2023-07-01 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 9357 | 0 |
2023-07-01 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 4787 | 63.95 |
2023-07-01 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Restricted Stock Units | 9357 | 0 |
2023-06-03 | Lenkowsky Adam | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 1077 | 0 |
2023-06-03 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 551 | 65.66 |
2023-06-03 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - M-Exempt | Restricted Stock Units | 1077 | 0 |
2023-05-03 | VESSEY RUPERT | EVP & President, Research | D - S-Sale | Common Stock, $0.10 par value | 50385 | 67.06 |
2023-05-01 | Lenkowsky Adam | EVP, Chief Commercial Officer | A - A-Award | Performance Shares | 8241 | 0 |
2023-05-01 | Lenkowsky Adam | EVP, Chief Commercial Officer | A - A-Award | Market Share Units | 5494 | 0 |
2023-05-02 | Greenlees Sharon | SVP & Controller | D - M-Exempt | Market Share Units | 689 | 0 |
2023-05-02 | Greenlees Sharon | SVP & Controller | D - M-Exempt | Restricted Stock Units | 328 | 0 |
2023-05-02 | Greenlees Sharon | SVP & Controller | A - M-Exempt | Common Stock, $0.10 par value | 328 | 0 |
2023-05-02 | Greenlees Sharon | SVP & Controller | A - M-Exempt | Common Stock, $0.10 par value | 689 | 0 |
2023-05-02 | Greenlees Sharon | SVP & Controller | D - J-Other | Common Stock, $0.10 par value | 62 | 0 |
2023-05-02 | Greenlees Sharon | SVP & Controller | D - F-InKind | Common Stock, $0.10 par value | 119 | 68.1 |
2023-05-02 | Greenlees Sharon | SVP & Controller | D - F-InKind | Common Stock, $0.10 par value | 227 | 68.1 |
2023-04-26 | Lenkowsky Adam | EVP, Chief Commercial Officer | I - | Common Stock, $0.10 par value | 0 | 0 |
2023-04-26 | Lenkowsky Adam | EVP, Chief Commercial Officer | I - | Common Stock, $0.10 par value | 0 | 0 |
2023-04-26 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - | Restricted Stock Units | 1077 | 0 |
2023-04-26 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - | Market Share Units | 8001 | 0 |
2023-04-26 | Lenkowsky Adam | EVP, Chief Commercial Officer | D - | Performance Shares | 12002 | 0 |
2023-04-26 | Lenkowsky Adam | EVP, Chief Commercial Officer | I - | Market Share Units | 1802 | 0 |
2023-04-26 | Lenkowsky Adam | EVP, Chief Commercial Officer | I - | Performance Shares | 3580 | 0 |
2023-03-31 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 486.943 | 0 |
2023-04-01 | Mily Elizabeth | EVP, Strategy & BD | A - M-Exempt | Common Stock, $0.10 par value | 2684 | 0 |
2023-04-01 | Mily Elizabeth | EVP, Strategy & BD | A - J-Other | Common Stock, $0.10 par value | 1190 | 0 |
2023-04-01 | Mily Elizabeth | EVP, Strategy & BD | D - F-InKind | Common Stock, $0.10 par value | 1139 | 69.31 |
2023-04-01 | Mily Elizabeth | EVP, Strategy & BD | A - M-Exempt | Common Stock, $0.10 par value | 3662 | 0 |
2023-04-01 | Mily Elizabeth | EVP, Strategy & BD | D - F-InKind | Common Stock, $0.10 par value | 2059 | 69.31 |
2023-04-01 | Mily Elizabeth | EVP, Strategy & BD | D - M-Exempt | Market Share Units | 3662 | 0 |
2023-04-01 | Mily Elizabeth | EVP, Strategy & BD | D - M-Exempt | Restricted Stock Units | 2684 | 0 |
2023-04-01 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | D - M-Exempt | Restricted Stock Units | 3306 | 0 |
2023-04-01 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - M-Exempt | Common Stock, $0.10 par value | 3306 | 0 |
2023-04-01 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | D - F-InKind | Common Stock, $0.10 par value | 1692 | 69.31 |
2023-03-31 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 108.209 | 0 |
2023-03-31 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 703.362 | 0 |
2023-03-31 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 486.943 | 0 |
2023-03-31 | Rice Derica W | director | A - A-Award | Deferred Share Units | 523.013 | 0 |
2023-03-31 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 523.013 | 0 |
2023-03-31 | Haller Julia A | director | A - A-Award | Deferred Share Units | 486.943 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | A - J-Other | Common Stock, $0.10 par value | 2683 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | A - M-Exempt | Common Stock, $0.10 par value | 21973 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | D - F-InKind | Common Stock, $0.10 par value | 10460 | 65.71 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | A - A-Award | Performance Shares | 21956 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | A - J-Other | Common Stock, $0.10 par value | 118 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | A - M-Exempt | Common Stock, $0.10 par value | 3658 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | D - F-InKind | Common Stock, $0.10 par value | 1602 | 65.71 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | A - J-Other | Common Stock, $0.10 par value | 657 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | A - M-Exempt | Common Stock, $0.10 par value | 4005 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | A - A-Award | Market Share Units | 14637 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | D - F-InKind | Common Stock, $0.10 par value | 1978 | 65.71 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | D - M-Exempt | Market Share Units | 3658 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | D - M-Exempt | Market Share Units | 4005 | 0 |
2023-03-10 | Mily Elizabeth | EVP, Strategy & BD | D - M-Exempt | Performance Shares | 21973 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | A - J-Other | Common Stock, $0.10 par value | 5438 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | A - M-Exempt | Common Stock, $0.10 par value | 44541 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | D - F-InKind | Common Stock, $0.10 par value | 25565 | 65.71 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | A - J-Other | Common Stock, $0.10 par value | 231 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | A - M-Exempt | Common Stock, $0.10 par value | 7147 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | A - J-Other | Common Stock, $0.10 par value | 1284 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | D - F-InKind | Common Stock, $0.10 par value | 3774 | 65.71 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | A - M-Exempt | Common Stock, $0.10 par value | 7824 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | A - J-Other | Common Stock, $0.10 par value | 1373 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | D - F-InKind | Common Stock, $0.10 par value | 4659 | 65.71 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | A - M-Exempt | Common Stock, $0.10 par value | 7423 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | D - F-InKind | Common Stock, $0.10 par value | 4500 | 65.71 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | D - M-Exempt | Market Share Units | 7147 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | D - M-Exempt | Market Share Units | 7824 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | D - M-Exempt | Market Share Units | 7423 | 0 |
2023-03-10 | VESSEY RUPERT | EVP & President, Research | D - M-Exempt | Performance Shares | 44541 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - J-Other | Common Stock, $0.10 par value | 4240 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - M-Exempt | Common Stock, $0.10 par value | 34726 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - F-InKind | Common Stock, $0.10 par value | 19916 | 65.71 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - J-Other | Common Stock, $0.10 par value | 173 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - M-Exempt | Common Stock, $0.10 par value | 5349 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - J-Other | Common Stock, $0.10 par value | 961 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - F-InKind | Common Stock, $0.10 par value | 2823 | 65.71 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - M-Exempt | Common Stock, $0.10 par value | 5856 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - J-Other | Common Stock, $0.10 par value | 1070 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - F-InKind | Common Stock, $0.10 par value | 3485 | 65.71 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - M-Exempt | Common Stock, $0.10 par value | 5787 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - J-Other | Common Stock, $0.10 par value | 2287 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - F-InKind | Common Stock, $0.10 par value | 3505 | 65.71 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - M-Exempt | Common Stock, $0.10 par value | 6272 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - F-InKind | Common Stock, $0.10 par value | 4375 | 65.71 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - A-Award | Performance Shares | 32494 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | A - A-Award | Market Share Units | 21663 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - M-Exempt | Market Share Units | 5349 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - M-Exempt | Market Share Units | 5856 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - M-Exempt | Market Share Units | 5787 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - M-Exempt | Performance Shares | 34726 | 0 |
2023-03-10 | LEUNG SANDRA | EVP, General Counsel | D - M-Exempt | Market Share Units | 6272 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - J-Other | Common Stock, $0.10 par value | 3069 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 25139 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 14429 | 65.71 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - A-Award | Performance Shares | 35129 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - J-Other | Common Stock, $0.10 par value | 154 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 4765 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - J-Other | Common Stock, $0.10 par value | 802 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 2517 | 65.71 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 4885 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 2909 | 65.71 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - J-Other | Common Stock, $0.10 par value | 775 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 4189 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 2540 | 65.71 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - A-Award | Market Share Units | 23419 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Market Share Units | 4765 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Market Share Units | 4885 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Market Share Units | 4189 | 0 |
2023-03-10 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Performance Shares | 25139 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - J-Other | Common Stock, $0.10 par value | 2500 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - M-Exempt | Common Stock, $0.10 par value | 20475 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - F-InKind | Common Stock, $0.10 par value | 9746 | 65.71 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - J-Other | Common Stock, $0.10 par value | 106 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - M-Exempt | Common Stock, $0.10 par value | 3275 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - F-InKind | Common Stock, $0.10 par value | 1435 | 65.71 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - J-Other | Common Stock, $0.10 par value | 588 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - M-Exempt | Common Stock, $0.10 par value | 3586 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - F-InKind | Common Stock, $0.10 par value | 1771 | 65.71 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - J-Other | Common Stock, $0.10 par value | 631 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - M-Exempt | Common Stock, $0.10 par value | 3412 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - F-InKind | Common Stock, $0.10 par value | 1716 | 65.71 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - J-Other | Common Stock, $0.10 par value | 1349 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - M-Exempt | Common Stock, $0.10 par value | 3699 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - F-InKind | Common Stock, $0.10 par value | 2142 | 65.71 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - A-Award | Performance Shares | 20199 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | A - A-Award | Market Share Units | 13466 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - M-Exempt | Market Share Units | 3275 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - M-Exempt | Market Share Units | 3586 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - M-Exempt | Market Share Units | 3412 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - M-Exempt | Performance Shares | 20475 | 0 |
2023-03-10 | Powell Ann | EVP, Chief Human Resources | D - M-Exempt | Market Share Units | 3699 | 0 |
2023-03-10 | Weese Michelle | EVP, Corporate Affairs | A - A-Award | Performance Shares | 9660 | 0 |
2023-03-10 | Weese Michelle | EVP, Corporate Affairs | A - A-Award | Market Share Units | 6440 | 0 |
2023-03-10 | Weese Michelle | EVP, Corporate Affairs | D - M-Exempt | Market Share Units | 1590 | 0 |
2023-03-10 | Weese Michelle | EVP, Corporate Affairs | A - J-Other | Common Stock, $0.10 par value | 51 | 0 |
2023-03-10 | Weese Michelle | EVP, Corporate Affairs | A - M-Exempt | Common Stock, $0.10 par value | 1590 | 0 |
2023-03-10 | Weese Michelle | EVP, Corporate Affairs | D - F-InKind | Common Stock, $0.10 par value | 594 | 65.71 |
2023-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | A - A-Award | Performance Shares | 19760 | 0 |
2023-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | A - A-Award | Market Share Units | 13173 | 0 |
2023-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | D - M-Exempt | Market Share Units | 2836 | 0 |
2023-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | A - J-Other | Common Stock, $0.10 par value | 92 | 0 |
2023-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | A - M-Exempt | Common Stock, $0.10 par value | 2836 | 0 |
2023-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | D - F-InKind | Common Stock, $0.10 par value | 1243 | 65.71 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - J-Other | Common Stock, $0.10 par value | 4206 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 34450 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 19773 | 65.71 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - J-Other | Common Stock, $0.10 par value | 214 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 6616 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - J-Other | Common Stock, $0.10 par value | 1146 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 3494 | 65.71 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 6985 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 4160 | 65.71 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - J-Other | Common Stock, $0.10 par value | 1062 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 5741 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - J-Other | Common Stock, $0.10 par value | 1940 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 3480 | 65.71 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 5319 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 3713 | 65.71 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - A-Award | Performance Shares | 40398 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - A-Award | Market Share Units | 26932 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - M-Exempt | Market Share Units | 6616 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - M-Exempt | Market Share Units | 6985 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - M-Exempt | Market Share Units | 5741 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - M-Exempt | Performance Shares | 34450 | 0 |
2023-03-10 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - M-Exempt | Market Share Units | 5319 | 0 |
2023-03-10 | Greenlees Sharon | SVP & Controller | A - A-Award | Performance Shares | 5269 | 0 |
2023-03-10 | Greenlees Sharon | SVP & Controller | A - A-Award | Market Share Units | 3513 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - J-Other | Common Stock, $0.10 par value | 5879 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 48152 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 27637 | 65.71 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - J-Other | Common Stock, $0.10 par value | 247 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 7652 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - J-Other | Common Stock, $0.10 par value | 1320 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 4041 | 65.71 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 8042 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - J-Other | Common Stock, $0.10 par value | 1484 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 4789 | 65.71 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 8025 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 4864 | 65.71 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - A-Award | Performance Shares | 47424 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | A - A-Award | Market Share Units | 31616 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Market Share Units | 7652 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Market Share Units | 8042 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Market Share Units | 8025 | 0 |
2023-03-10 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Performance Shares | 48152 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - J-Other | Common Stock, $0.10 par value | 17148 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - M-Exempt | Common Stock, $0.10 par value | 140445 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - F-InKind | Common Stock, $0.10 par value | 80594 | 65.71 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - J-Other | Common Stock, $0.10 par value | 718 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - M-Exempt | Common Stock, $0.10 par value | 22214 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - J-Other | Common Stock, $0.10 par value | 3908 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - F-InKind | Common Stock, $0.10 par value | 11728 | 65.71 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - M-Exempt | Common Stock, $0.10 par value | 23817 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - J-Other | Common Stock, $0.10 par value | 4328 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - F-InKind | Common Stock, $0.10 par value | 14179 | 65.71 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - M-Exempt | Common Stock, $0.10 par value | 23407 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - J-Other | Common Stock, $0.10 par value | 9042 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - F-InKind | Common Stock, $0.10 par value | 14184 | 65.71 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - M-Exempt | Common Stock, $0.10 par value | 24793 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - F-InKind | Common Stock, $0.10 par value | 17304 | 65.71 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - A-Award | Performance Shares | 140515 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | A - A-Award | Market Share Units | 93677 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - M-Exempt | Market Share Units | 22214 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - M-Exempt | Market Share Units | 23817 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - M-Exempt | Market Share Units | 23407 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - M-Exempt | Performance Shares | 140445 | 0 |
2023-03-10 | Caforio Giovanni | Board Chair and CEO | D - M-Exempt | Market Share Units | 24793 | 0 |
2023-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - A-Award | Performance Shares | 19760 | 0 |
2023-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - A-Award | Market Share Units | 13173 | 0 |
2023-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | D - M-Exempt | Market Share Units | 2447 | 0 |
2023-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - J-Other | Common Stock, $0.10 par value | 79 | 0 |
2023-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - M-Exempt | Common Stock, $0.10 par value | 2447 | 0 |
2023-03-10 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | D - F-InKind | Common Stock, $0.10 par value | 914 | 65.71 |
2023-02-06 | Caforio Giovanni | Board Chair and CEO | D - S-Sale | Common Stock, $0.10 par value | 240000 | 74.65 |
2023-02-06 | Powell Ann | EVP, Chief Human Resources | D - S-Sale | Common Stock, $0.10 par value | 11183 | 74.69 |
2023-02-01 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | Price Paula A | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | Rice Derica W | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | Haller Julia A | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | D - M-Exempt | Restricted Stock Units | 2543 | 0 |
2023-02-01 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | A - M-Exempt | Common Stock, $0.10 par value | 2543 | 0 |
2023-02-01 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | D - F-InKind | Common Stock, $0.10 par value | 731 | 71.23 |
2023-02-01 | Vousden Karen H | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2023-02-01 | Hidalgo Medina Manuel | director | A - A-Award | Deferred Share Units | 2807.806 | 0 |
2022-12-31 | Haller Julia A | director | A - A-Award | Deferred Share Units | 469.076 | 71.95 |
2022-12-31 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 469.076 | 71.95 |
2022-12-31 | Hidalgo Medina Manuel | director | A - A-Award | Deferred Share Units | 117.269 | 71.95 |
2022-12-31 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 469.076 | 71.95 |
2022-12-31 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 677.554 | 71.95 |
2022-12-31 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 104.239 | 71.95 |
2022-12-31 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 503.822 | 71.95 |
2022-12-31 | Rice Derica W | director | A - A-Award | Deferred Share Units | 503.822 | 71.95 |
2022-12-02 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | A - M-Exempt | Common Stock, $0.10 par value | 2637 | 0 |
2022-12-02 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - F-InKind | Common Stock, $0.10 par value | 1349 | 81.13 |
2022-12-02 | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | D - M-Exempt | Restricted Stock Units | 2637 | 0 |
2022-12-02 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 8792 | 0 |
2022-12-02 | Elkins David V | EVP, Chief Financial Officer | D - F-InKind | Common Stock, $0.10 par value | 4498 | 81.13 |
2022-12-02 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Restricted Stock Units | 8792 | 0 |
2022-12-02 | VESSEY RUPERT | EVP, Research & Early Dev. | A - M-Exempt | Common Stock, $0.10 par value | 8792 | 0 |
2022-12-02 | VESSEY RUPERT | EVP, Research & Early Dev. | D - F-InKind | Common Stock, $0.10 par value | 4498 | 81.13 |
2022-12-02 | VESSEY RUPERT | EVP, Research & Early Dev. | D - M-Exempt | Restricted Stock Units | 8792 | 0 |
2022-11-09 | Powell Ann | EVP, Chief Human Resources | D - S-Sale | Common Stock, $0.10 par value | 16250 | 80.45 |
2022-11-07 | VESSEY RUPERT | EVP, Research & Early Dev. | A - M-Exempt | Common Stock, $0.10 par value | 8491 | 38.41 |
2022-11-07 | VESSEY RUPERT | EVP, Research & Early Dev. | A - M-Exempt | Common Stock, $0.10 par value | 8491 | 47.81 |
2022-11-07 | VESSEY RUPERT | EVP, Research & Early Dev. | A - M-Exempt | Common Stock, $0.10 par value | 8491 | 44.7 |
2022-11-07 | VESSEY RUPERT | EVP, Research & Early Dev. | A - M-Exempt | Common Stock, $0.10 par value | 21288 | 72.42 |
2022-11-07 | VESSEY RUPERT | EVP, Research & Early Dev. | D - S-Sale | Common Stock, $0.10 par value | 45910 | 78.88 |
2022-11-07 | VESSEY RUPERT | EVP, Research & Early Dev. | A - M-Exempt | Common Stock, $0.10 par value | 5843 | 70.89 |
2022-11-07 | VESSEY RUPERT | EVP, Research & Early Dev. | D - M-Exempt | Option (right to buy) | 8491 | 0 |
2022-09-30 | Rice Derica W | director | A - A-Award | Deferred Share Units | 509.917 | 71.09 |
2022-09-30 | Bhatt Deepak | director | A - A-Award | Deferred Share Units | 105.5 | 71.09 |
2022-09-30 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 509.917 | 71.09 |
2022-09-30 | Haller Julia A | director | A - A-Award | Deferred Share Units | 474.75 | 71.09 |
2022-09-30 | Hidalgo Medina Manuel | director | A - A-Award | Deferred Share Units | 118.688 | 71.09 |
2022-09-30 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 685.75 | 71.09 |
2022-09-30 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 474.75 | 71.09 |
2022-09-30 | Arduini Peter J | director | A - A-Award | Deferred Share Units | 474.75 | 71.09 |
2022-09-20 | Caforio Giovanni | Board Chair and CEO | D - S-Sale | Common Stock, $0.10 par value | 25000 | 69.71 |
2022-09-15 | Caforio Giovanni | Board Chair and CEO | D - S-Sale | Common Stock, $0.10 par value | 50000 | 71.84 |
2022-09-13 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 121214 | 48.49 |
2022-09-13 | Elkins David V | EVP, Chief Financial Officer | D - S-Sale | Common Stock, $0.10 par value | 103951 | 71.29 |
2022-09-13 | Elkins David V | EVP, Chief Financial Officer | A - M-Exempt | Common Stock, $0.10 par value | 2063 | 48.49 |
2022-09-13 | Elkins David V | EVP, Chief Financial Officer | D - S-Sale | Common Stock, $0.10 par value | 30000 | 71.35 |
2022-09-13 | Elkins David V | EVP, Chief Financial Officer | D - M-Exempt | Option (right to buy) | 121214 | 48.49 |
2022-09-14 | Powell Ann | EVP, Chief Human Resources | D - S-Sale | Common Stock, $0.10 par value | 25000 | 70.75 |
2022-06-30 | YALE PHYLLIS R | A - A-Award | Deferred Share Units | 438.312 | 77 | |
2022-06-30 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 438.312 | 0 |
2022-06-30 | Arduini Peter J | A - A-Award | Deferred Share Units | 438.312 | 77 | |
2022-06-30 | Hidalgo Medina Manuel | A - A-Award | Deferred Share Units | 97.403 | 77 | |
2022-07-01 | Weese Michelle | EVP, Corporate Affairs | D - M-Exempt | Restricted Stock Units | 1885 | 0 |
2022-07-01 | Weese Michelle | EVP, Corporate Affairs | D - F-InKind | Common Stock, $0.10 par value | 682 | 76.84 |
2022-06-30 | Storch Gerald L | A - A-Award | Deferred Share Units | 470.779 | 77 | |
2022-06-30 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 470.779 | 0 |
2022-06-30 | Rice Derica W | director | A - A-Award | Deferred Share Units | 470.779 | 0 |
2022-06-30 | Rice Derica W | A - A-Award | Deferred Share Units | 470.779 | 77 | |
2022-06-30 | Bhatt Deepak | A - A-Award | Deferred Share Units | 18.146 | 77 | |
2022-06-30 | Haller Julia A | A - A-Award | Deferred Share Units | 438.312 | 77 | |
2022-06-30 | Haller Julia A | director | A - A-Award | Deferred Share Units | 438.312 | 0 |
2022-07-01 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A - M-Exempt | Common Stock, $0.10 par value | 9356 | 0 |
2022-07-01 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - F-InKind | Common Stock, $0.10 par value | 4786 | 76.84 |
2022-07-01 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | D - M-Exempt | Restricted Stock Units | 9356 | 0 |
2022-06-30 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 633.117 | 0 |
2022-06-30 | Samuels Theodore R. II | A - A-Award | Deferred Share Units | 633.117 | 77 | |
2022-06-14 | Bhatt Deepak | A - A-Award | Deferred Share Units | 1737.002 | 72.87 | |
2022-06-14 | Bhatt Deepak | - | 0 | 0 | ||
2022-06-13 | Caforio Giovanni | Board Chair and CEO | D - S-Sale | Common Stock, $0.10 par value | 30000 | 74.04 |
2022-06-03 | Haller Julia A | director | A - M-Exempt | Common Stock, $0.10 par value | 2949 | 0 |
2022-06-03 | Haller Julia A | D - M-Exempt | Restricted Stock Units | 2949 | 0 | |
2022-06-06 | LEUNG SANDRA | EVP, General Counsel | D - S-Sale | Common Stock, $0.10 par value | 65000 | 74.89 |
2022-04-25 | Greenlees Sharon | officer | - | 0 | 0 | |
2022-05-02 | Greenlees Sharon | SVP & Controller | A - A-Award | Market Share Units | 2756 | 0 |
2022-03-31 | Samuels Theodore R. II | A - A-Award | Deferred Share Units | 667.534 | 73.03 | |
2022-03-31 | Samuels Theodore R. II | director | A - A-Award | Deferred Share Units | 667.534 | 0 |
2022-03-31 | Storch Gerald L | A - A-Award | Deferred Share Units | 496.371 | 73.03 | |
2022-03-31 | Storch Gerald L | director | A - A-Award | Deferred Share Units | 496.371 | 0 |
2022-03-31 | Hidalgo Medina Manuel | A - A-Award | Deferred Share Units | 102.698 | 73.03 | |
2022-03-31 | YALE PHYLLIS R | director | A - A-Award | Deferred Share Units | 462.139 | 0 |
2022-03-31 | YALE PHYLLIS R | A - A-Award | Deferred Share Units | 462.139 | 73.03 | |
2022-03-31 | Haller Julia A | A - A-Award | Deferred Share Units | 462.139 | 73.03 | |
2022-03-31 | Haller Julia A | director | A - A-Award | Deferred Share Units | 462.139 | 0 |
2022-03-31 | Arduini Peter J | A - A-Award | Deferred Share Units | 462.139 | 73.03 | |
2022-03-31 | Rice Derica W | A - A-Award | Deferred Share Units | 496.371 | 73.03 | |
2022-03-31 | Rice Derica W | director | A - A-Award | Deferred Share Units | 496.371 | 0 |
2022-04-01 | Mily Elizabeth | EVP, Strategy & BD | A - M-Exempt | Common Stock, $0.10 par value | 2685 | 0 |
2022-04-01 | Mily Elizabeth | EVP, Strategy & BD | A - J-Other | Common Stock, $0.10 par value | 1508 | 0 |
2022-04-01 | Mily Elizabeth | EVP, Strategy & BD | D - F-InKind | Common Stock, $0.10 par value | 1139 | 73.82 |
2022-04-01 | Mily Elizabeth | EVP, Strategy & BD | A - M-Exempt | Common Stock, $0.10 par value | 3662 | 0 |
2022-04-01 | Mily Elizabeth | EVP, Strategy & BD | D - F-InKind | Common Stock, $0.10 par value | 2194 | 73.82 |
2022-04-01 | Mily Elizabeth | EVP, Strategy & BD | D - M-Exempt | Market Share Units | 3662 | 0 |
2022-04-01 | Mily Elizabeth | EVP, Strategy & BD | D - M-Exempt | Restricted Stock Units | 2685 | 0 |
2022-04-01 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | A - A-Award | Restricted Stock Units | 13225 | 0 |
2022-03-21 | Caforio Giovanni | Board Chair and CEO | D - S-Sale | Common Stock, $0.10 par value | 25000 | 71.52 |
2022-03-21 | Caforio Giovanni | Board Chair and CEO | D - G-Gift | Common Stock, $0.10 par value | 420 | 0 |
2022-03-16 | VESSEY RUPERT | EVP, Research & Early Dev. | A - M-Exempt | Common Stock, $0.10 par value | 8490 | 38.41 |